Tag: ADC development
Opportunities for ADC Development and Manufacturing
At the 2022 World ADC Conference in San Diego, Stewart Mitchell, Executive Vice President and site head of Sterling Pharma Solutions' Deeside, U.K. facility, presented a case study on the development and GMP manufacture at the site.
Abzena to Offer New, Integrated, Clinical Translation Service
Abzena, a life sciences company providing a series of specific serviced for the development of antibody-drug conjugates, earlier this week announced the launch of...
Antibody-drug Conjugate Development
Antibody-drug conjugates (ADCs) are a new implementation of an old idea: using antibodies to deliver toxic payloads directly to tumor cells. The antibody serves...
PepTalk: The Protein Science Week – New Horizons, New Goals
This year PepTalk: The Protein Science Week, one of the largest annual gatherings of protein science researchers in the world - now in its...
Q&A – an Interview with Lonza’s Laurent Ducry
Antibody-drug Conjugates or ADCs are among the most exciting drug developments of the last decade. The combination of potent, small molecule drugs with the...
